{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T19:38:16Z","timestamp":1774726696332,"version":"3.50.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1093\/ajcp\/aqx041","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:55:58Z","timestamp":1488329758000},"page":"33-41","source":"Crossref","is-referenced-by-count":15,"title":["Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders"],"prefix":"10.1093","volume":"148","author":[{"given":"Emily F","family":"Mason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Pozdnyakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M","family":"Dorfman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"key\n\t\t\t\t20170811075040_CIT0001","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2567.2001.01163.x","article-title":"The unusual distribution of the neuronal\/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans","volume":"102","year":"2001","journal-title":"Immunology"},{"key":"key\n\t\t\t\t20170811075040_CIT0002","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1073\/pnas.0510081103","article-title":"Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation","volume":"103","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170811075040_CIT0003","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1182\/blood-2006-06-029355","article-title":"CD200 is a new prognostic factor in multiple myeloma","volume":"108","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170811075040_CIT0004","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.leu.2404559","article-title":"CD200 as a prognostic factor in acute myeloid leukaemia","volume":"21","year":"2007","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170811075040_CIT0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1309\/AJCP59UORCYZEVQO","article-title":"Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma","volume":"137","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20170811075040_CIT0006","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1309\/AJCP38XRRUGSQOVC","article-title":"CD200 (OX-2 membrane glycoprotein) expression in B cell-derived neoplasms","volume":"134","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20170811075040_CIT0007","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/leu.2012.77","article-title":"Expression of CD200 on AML blasts directly suppresses memory T-cell function","volume":"26","year":"2012","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170811075040_CIT0008","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/leu.2011.1","article-title":"CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia","volume":"25","year":"2011","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170811075040_CIT0009","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1309\/AJCPEBK31VQQNDDR","article-title":"CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders","volume":"140","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20170811075040_CIT0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cyto.b.21128","article-title":"CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry","volume":"86","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"key\n\t\t\t\t20170811075040_CIT0011","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1309\/AJCPBV9ELXC0ECVL","article-title":"Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging","volume":"142","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20170811075040_CIT0012","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ijlh.12315","article-title":"Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms","volume":"37","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"key\n\t\t\t\t20170811075040_CIT0013","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.3109\/10428194.2015.1030642","article-title":"Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis","volume":"56","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20170811075040_CIT0014","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2009.07644.x","article-title":"CD200\/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells","volume":"145","year":"2009","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20170811075040_CIT0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.17.1.297","article-title":"The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids","volume":"17","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t20170811075040_CIT0016","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t20170811075040_CIT0017","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1309\/AJCP2F2DOXOTXHZA","article-title":"The diagnostic value of CD1D expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders","volume":"136","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20170811075040_CIT0018","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.4049\/jimmunol.1003615","article-title":"CD1D and CD1C expression in human B cells is regulated by activation and retinoic acid receptor signaling","volume":"186","year":"2011","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170811075040_CIT0019","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.leukres.2013.12.015","article-title":"CD1D expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis","volume":"38","year":"2014","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t20170811075040_CIT0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/10428194.2013.803222","article-title":"CD1D expression as a prognostic marker for chronic lymphocytic leukemia","volume":"55","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20170811075040_CIT0021","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1309\/AJCPL13YDUHFKPJU","article-title":"Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics","volume":"131","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20170811075040_CIT0022","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170811075040_CIT0023","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170811075040_CIT0024","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":"High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias","volume":"46","year":"2014","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170811075040_CIT0025","first-page":"1","article-title":"Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant","volume":"8194","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20170811075040_CIT0026","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","year":"2012","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20170811075040_CIT0027","doi-asserted-by":"crossref","first-page":"e83244","DOI":"10.1371\/journal.pone.0083244","article-title":"Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma","volume":"8","year":"2013","journal-title":"PLos One"},{"key":"key\n\t\t\t\t20170811075040_CIT0028","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","year":"2015","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170811075040_CIT0029","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","year":"2016","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170811075040_CIT0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11864-014-0285-5","article-title":"Update on the biology and treatment options for hairy cell leukemia","volume":"15","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"key\n\t\t\t\t20170811075040_CIT0031","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.4049\/jimmunol.178.9.5595","article-title":"CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy","volume":"178","year":"2007","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170811075040_CIT0032","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.180.2.699","article-title":"Blockade of CD200 in the presence or absence of antibody effector function: implications for anti-CD200 therapy","volume":"180","year":"2008","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170811075040_CIT0033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14712598.8.1.5","article-title":"Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression","volume":"8","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"key\n\t\t\t\t20170811075040_CIT0034","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.leukres.2008.08.021","article-title":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade","volume":"33","year":"2009","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t20170811075040_CIT0035","first-page":"1","article-title":"The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse","volume":"1","year":"2015","journal-title":"Leukemia"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/148\/1\/33\/19501364\/aqx041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T05:39:46Z","timestamp":1568871586000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ajcp\/article\/148\/1\/33\/3860185\/Flow-Cytometric-Patterns-of-CD200-and-CD1d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqx041","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,1]]}}}